Evidence topic
These reviews start from a claim a reader has already met — on a menu, in an advertisement, in a summary written by someone selling the compound — and test it against what has been published.
The verdict leads. A review that buries its answer under a survey of the literature has failed the reader who arrived with the question.
13 reviews · page 2 of 2
Does the evidence behind tesamorelin's approval support general fat loss?
No. Every trial the approval rests on enrolled adults with HIV-associated lipodystrophy, and the one randomized trial of body composition outside that population reduced visceral fat while leaving subcutaneous fat statistically unchanged, at p equal to 0.40.
A review argues from the ledger; the ledger itself is published as reference tables, and every molecule’s dated posture is in the molecule index. Terms of art are defined in the glossary.